We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
CALL
Philip Morris
PM
$299B
| $2.22M | 0.06% |
+25,000
| New | +$2.12M |
|
|
377
PUT
Philip Morris
PM
$299B
| $2.22M | 0.06% |
+25,000
| New | +$2.12M |
|
|
STKL
378
PUT
DELISTED
SunOpta
STKL
| $2.22M | 0.06% |
+150,000
| New | +$2.15M |
|
379
CALL
Blink Charging
BLNK
$70.4M
| $2.2M | 0.06% |
+53,500
| New | +$2.33M |
|
380
Teva Pharmaceuticals
TEVA
$41.2B
| $2.19M | 0.05% |
190,000
+39,700
| +26% | +$455K |
|
381
Starbucks
SBUX
$121B
| $2.19M | 0.05% |
20,000
-3,500
| -15% | -$367K |
|
382
CALL
Dave & Buster's
PLAY
$377M
| $2.16M | 0.05% |
+45,000
| New | +$1.76M |
|
383
Arrowhead Research
ARWR
$12.3B
| $2.15M | 0.05% |
+32,500
| New | +$2.52M |
|
|
PRPB
384
CALL
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $2.15M | 0.05% |
+218,500
| New | +$2.29M |
|
385
CALL
Vertex Pharmaceuticals
VRTX
$122B
| $2.15M | 0.05% |
10,000
| – | – |
|
|
386
PUT
Vertex Pharmaceuticals
VRTX
$122B
| $2.15M | 0.05% |
10,000
| – | – |
|
387
CALL
Floor & Decor
FND
$5.98B
| $2.15M | 0.05% |
+22,500
| New | +$2.19M |
|
388
CALL
HF Sinclair
DINO
$16.7B
| $2.15M | 0.05% |
+60,000
| New | +$2M |
|
389
CALL
Spotify
SPOT
$107B
| $2.14M | 0.05% |
8,000
-52,000
| -87% | -$16.2M |
|
390
CALL
Devon Energy
DVN
$50.9B
| $2.14M | 0.05% |
+98,000
| New | +$2.02M |
|
391
CRISPR Therapeutics
CRSP
$4.77B
| $2.13M | 0.05% |
+17,500
| New | +$2.64M |
|
392
PUT
iShares Semiconductor ETF
SOXX
$41.7B
| $2.12M | 0.05% |
15,000
| – | – |
|
|
SEM
393
CALL
DELISTED
Select Medical
SEM
| $2.11M | 0.05% |
+115,072
| New | +$1.89M |
|
394
JD.com
JD
$43.6B
| $2.11M | 0.05% |
25,000
+17,500
| +233% | +$1.6M |
|
395
CALL
Coca-Cola
KO
$381B
| $2.11M | 0.05% |
40,000
-94,700
| -70% | -$4.77M |
|
|
SPLK
396
PUT
DELISTED
Splunk Inc
SPLK
| $2.1M | 0.05% |
15,500
-17,000
| -52% | -$2.65M |
|
397
CALL
Chevron
CVX
$383B
| $2.1M | 0.05% |
20,000
-44,400
| -69% | -$4.34M |
|
398
CALL
Palantir
PLTR
$293B
| $2.1M | 0.05% |
90,000
| – | – |
|
|
PXD
399
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $2.1M | 0.05% |
+13,200
| New | +$1.87M |
|
|
SGEN
400
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.08M | 0.05% |
+15,000
| New | +$2.42M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.